Journal of Oncology / 2008 / Article / Tab 5

Clinical Study

CYP1A1, mEH, and GSTM1 Polymophisms and Risk of Oral and Pharyngeal Cancer: A Spanish Case-Control Study

Table 5

Combination of polymorphisms mEH and GSTM1 and risk of oropharyngeal cancer.

Combination of genetic polymorphisms Cases Controls OR crude OR adjusted

mEH (Arg/Arg)/GSTM1 present 31481.001.00
mEH (Arg/Arg)/GSTM1 absent 32401.22 (0.63–2.36)1.45 (0.66–3.17)
mEH mutated/GSTM1 present 14201.15 (0.50–2.65)1,19 (0.43–3.27)
mEH mutated/GSTM1 absent 15221.18 (0.52–2.66)1.07 (0.39–2.92).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.